Ad
related to: pfizer 2024 newsinsights.pfizer.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
The $771 million adjustment to the estimated revenue reversal of $3.5 billion last quarter reflects 1.4 million fewer treatment courses returned by the U.S. government through Feb. 29, 2024 versus ...
Pharmaceuticals giant Pfizer (NYSE:PFE) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. The company reported an adjusted earnings ...
On the cost side, Pfizer achieved $4 billion in savings and announced an additional $1.5 billion in margin improvements. In R&D, leadership changed for the first time in 15 years,
Pfizer reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and its stock remained flat after market open.Pfizer reported $63.6 billion in ...
Pfizer (NYSE: PFE) Q4 2024 Earnings Call Feb 04, 2025, 10:30 a.m. ET. Contents: ... The good news is that if it was a question of capabilities to improve R&D productivity, that would be a ...
Pfizer (NYSE: PFE) Q3 2024 Earnings Call Oct 29, 2024, 10:00 a.m. ET. Contents: Prepared Remarks. ... And then, second one, sort of tie to the brighter news from a few weeks ago. We noticed the ...
In July 2024, Pfizer announced topline results from the Phase 3 AFFINE trial of giroctocogene fitelparvovec, which demonstrated that the trial met the primary and key secondary objectives of ...
Pfizer on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, a move top executives said provided a more reliable view of its COVID-19 business than ...